What a Vascular Surgeon Should Know About Familial Abdominal Aortic Aneurysm  by van de Luijtgaarden, K.M. & Verhagen, H.J.M.
Eur J Vasc Endovasc Surg (2015) 50, 137e138EDITORIALWhat a Vascular Surgeon Should Know About Familial Abdominal Aortic
AneurysmA genetic susceptibility for abdominal aortic aneurysm
(AAA) may explain the high prevalence of patients with a
positive family history for aortic aneurysms (i.e., familial
AAA). The results from recent studies have implications for
daily practice with regard to identifying patients with fa-
milial AAA, screening of relatives, and treatment strategies.
Classifying patients as “familial” is important, as relatives
have an increased risk of developing an AAA with time.
Several deﬁnitions have been used in the literature, the most
common being when at least one ﬁrst-degree relative (parent,
sibling, offspring) is diagnosed with an aortic aneurysm.1
Patients with a negative (or uninformative) family history
are usually classiﬁed as having a sporadic AAA. Familial AAA
can be assessed by information from family history alone, or
by screening relatives. However, both methods have short-
comings. Family history alone usually underestimates the true
prevalence, as patients may not be aware that relatives have
been diagnosed with an AAA or the relatives are too young to
have developed an aneurysm yet. Screening relatives with a
single ultrasound scan may be of limited beneﬁt, as they may
develop aneurysms over time. Furthermore, this can only be
undertaken in relatives who are alive, willing and capable of
undergoing screening.
Based upon family history review, the proportion of pa-
tients with AAA with familial AAA is around 13% (range 6e
36%).2 Ultrasound screening of the relatives of those with
AAAs suggests a prevalence of 17% (range 9e29%) in men
and 4% (range 0e11%) in women.2 The prevalence of AAA in
age-selected general populations is around 6% (range 4e8%)
in men and 1% (range 1e2%) in women.3 Accordingly, rela-
tives of patients with AAAs have a 2e3-fold excess risk of
developing an AAA in their lifetime.
One question is whether patients with familial AAA are
clinically different. One may hypothesize that in patients with
AAA with a high genetic risk, other risk factors may be less
important. Studies suggest that patients with familial AAA are
signiﬁcantly more likely to be female, younger, have fewer
cardiovascular risk factors (e.g., hypertension and diabetes
mellitus), and possibly have a lower carotid intima-media
thickness.1 However, a distinctive and clinically useful
phenotype for accurately predicting patients with familial
AAA has not been established. Studies also show a high rate
of thoracic aortic aneurysms and an increased rate of bilateral
iliac aneurysms in patients with familial AAA,4 and this could1078-5884/$ e see front matter  2015 European Society for Vascular Surg
http://dx.doi.org/10.1016/j.ejvs.2015.03.036partly explain the high prevalence of thoracic aneurysms in
patients with AAAs.5 Relatives of patients with familial AAA
also appear to have increased aortic diameters,6 supporting
the hypothesis of a systemic involvement. Additional analyses
of patients with familial and their relatives are needed to
increase knowledge on this matter.
To answer the question of why patients with familial AAA
are different, one must understand the mode of inheritance
of possible genetic defects. In some families, a major genetic
defect with a high risk of recurrence (e.g., an autosomal
dominant inheritance pattern with reduced penetrance) is
expected.7 Other families exhibit more complex genetics with
lower recurrence risks. In any case, additional environmental
effects, such as smoking, hypertension and hypercholester-
olemia could enhance the risk of aneurysm formation and
therefore explain the variability in expression of the disease.
It is also crucial to realize that these families have many
environmental risk factors in common, leading to a possible
overestimation of any genetic effect.
Most accepted genetic aortic aneurysm syndromes are
caused by defects in genes involved in the transforming
growth factor-b pathway,8 and are associated with syn-
dromes like Marfan disease and LoeyseDietz syndrome.
These predominantly affect the thoracic aorta but can also
affect the abdominal aorta. Interestingly, no causative genes
have been found (as yet) in familial AAA. The main reason
for this is that familial AAA is a late-onset disease, making it
difﬁcult to collect DNA samples from a sufﬁcient number of
affected relatives to perform genetic linkage studies. Until
now, family studies have detected a linkage with the 19q13
and 4q31 regions in the genome but without identifying
speciﬁc genes in these regions.9,10 In order to further
establish the genetics of AAA formation, other strategies,
including genome-wide association studies, have been
explored. Currently described associations of a genome-
wide single nucleotide polymorphism with AAA include
DAB2IP, LRP1, LDLR, ANRIl, and SORT1.10 Having one of
these alleles results in an additional 20% risk for devel-
oping AAA; however, the causal relationship of these poly-
morphisms still needs to be elucidated. Novel
improvements in next-generation sequencing techniques
should enable the identiﬁcation of causative genes in the
near future, which would lead to a signiﬁcant impact on
treatment strategies and screening of high-risk populations.ery. Published by Elsevier Ltd. All rights reserved.
138 EditorialBecause relatives of patients with AAAs have an increased
risk of developing aneurysms and are a relatively easy pop-
ulation to identify, they may form an attractive subgroup to
offer screening to. Adequate estimates of risk per relative
(parents, siblings, and children) stratiﬁed by sex are needed
but are currently lacking. The present American College of
Cardiology/American Heart Association guidelines recom-
mend ultrasound screening for male relatives aged 60 years
or older, while the European Society for Vascular Surgery
guidelines recommend ultrasound screening of both male and
female relatives aged >50 years who have a family history of
AAA. Recent data from large screening programs show a
lower incidence of AAA than expected,11 questioning the ef-
ﬁcacy of population screening. Screening relatives of patients
with AAAs may therefore be a more efﬁcient alternative.
Another issue for debate is the optimal timing of any
intervention. Patients with familial AAA seem to show
accelerated aneurysm growth,12 which could partly be
explained by the higher rate of females, where increased
growth rates have been observed. Interestingly, this could
partly explain the observed higher rate of aneurysm rupture
in familial AAA,13 raising the question as to whether patients
with familial AAA should be treated at a younger age.
It is not known whether endovascular aneurysm repair
(EVAR) or open repair (OR) is the optimal treatment for
patients with familial AAA. Only very limited data are
available; however, as patients with familial AAA tend to be
younger, they may beneﬁt from OR, which carries a lower
secondary intervention risk with time. However, one study
has reported that late failure after OR was independently
associated with a positive family history for AAA.14
Regarding outcomes after EVAR, a trend towards a higher
aneurysm-related mortality in patients with familial AAA has
been reported,15 while others have shown that patients
with familial AAA seem to develop more aneurysm-related
complications without an increase in all-cause mortality.16
Accordingly, the available data suggest worse outcomes
for patients with familial AAA undergoing both EVAR and
OR; however, longer term follow-up and data from large
international registries will be needed to deﬁne the optimal
treatment and follow-up strategies in these patients.
In conclusion, accumulating knowledge suggests a genetic
component in the formation of AAA and new genetic tech-
niques may lead to the identiﬁcation of causative genes,
which could have a signiﬁcant impact on treatment strategies
and the screening of high-risk populations. Patients with fa-
milial AAAs may react differently to types of operative repair
and may need modiﬁed postoperative surveillance pro-
grammes, emphasizing the need to collect family histories.
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